Chagas Disease
We started a pilot project on Chagas Disease, which is a major disease in Latin America.
Read moreAuthor: Folding@Home
FAH researcher Dr. Veena Thomas has proposed a novel therapeutic strategy for HD
FAH researcher Dr. Veena Thomas has proposed a novel therapeutic strategy for HD and this proposal looks to be funded by NIH (as of September 22, 2010 still pending). This…
Read moreWorking closely with the Nanomedicine Center for Protein Folding
We have been working closely with the Nanomedicine Center for Protein Folding on pushing our lead compounds forward. They have gone from the test tube to the first round of…
Read moreFAH/Pande Group researcher Paul Novick has applied ligand-based methods to Chagas disease
FAH/Pande Group researcher Paul Novick has applied ligand-based methods to Chagas disease and in collaboration with the SPARK project (UCSF) and the McKerrow Lab (UCSF) has started to test the…
Read morePilot project on Chagas Disease
We started a pilot project on Chagas Disease.
Read moreCollaboration with the Nanomedicine Center for Protein Folding
In collaboration with the Nanomedicine Center for Protein Folding, we have been using our methods to further push a chaperonin inhibitor. This next round will use new scoring functions from…
Read moreNew paper on Huntingtons
Our new paper #62: “The predicted structure of the headpiece of the Huntington protein and its implications for Huntington’s Disease.” just came out in the Journal of Molecular Biology.
Read moreExciting results regarding new possible drug leads for Alzheimer’s
We have had some exciting results regarding new possible drug leads for Alzheimer’s. We hope to be submitting these soon for publication.
Read moreNew Protomol (Core B4) core to study enzyme in some kinds of cancer
We’ve been using our new Protomol (Core B4) core to study the activation of src Kinase, an enzyme that is involved in the onset of some kinds of cancer.
Read moreNew software methods for the chaperonin inhibitor project
Del has been involved in the development of new software methods (Ocker) for the chaperonin inhibitor project.
Read more